New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

New Biomarkers and Therapeutic Targets in Osteoporosis Via Omics Technologies — Stella

Home/Osteoporosis, Postmenopausal/

View on ClinicalTrials.gov

Recruiting

Back to Osteoporosis, Postmenopausal trials

Trial locations(1 site)

Greece

Laboratory for Research of the Musculoskeletal System, Kifissia, Attica

Key details

Sponsor

National and Kapodistrian University of Athens

Collaborators

National Hellenic Research Foundation

Enrollment target

~60 participants

Started

July 2024

Primary completion

October 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Sex

Female only

Last updated July 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.